(CNN) – More than 230,000 bottles of an antidepressant are being recalled.
The medication contains levels of a chemical that pose a cancer risk.
The medication, Duloxetine, was sold by Rising Pharmaceuticals of New Jersey.
The company voluntarily recalled the capsules last month.
But now the Food and Drug Administration (FDA) has classified it under its second-most severe risk level.
That means it could cause temporary or medically reversible adverse health consequences.
A similar recall of more than seven thousand bottles of Duloxetine distributed by Towa Pharmaceutical Europe was issued in October.
According to the FDA, the recalled lot was #220128, expiring December 2024.
If you take Duloxetine, it’s important to carefully read the label and the recall notice to see if your medication is impacted.
If you’re unsure, contact your pharmacist or physician to confirm and seek an alternative medication.
Visit fda.gov for more information.
